Parenteral methotrexate or gold for rheumatoid arthritis: a follow up
Suarez-Almazor, M.E.; Russell, A.S.
Clinical and Experimental Rheumatology 8(2): 163-166
1990
ISSN/ISBN: 0392-856X PMID: 2110877 Document Number: 360620
The forty participants in a double blind controlled trial of parenteral methotrexate or gold for RA were followed up two years later. Fifty percent had remained on the original medication, 13/20 on MTX and 7/20 on gold. Only 5 and 3 of them respectively had no active joint swelling. No major differences between the two groups were seen.